Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
01 4Mission | CDMO
02 6Strides Pharma Science
03 2ANI Pharmaceuticals Inc
04 1Acarpia Farmaceutici
05 6Advicenne
06 3Ajanta Pharma Limited
07 2Alliance Pharmaceutical Company
08 3Ascent Innovative Medicines
09 2Bionpharma
10 1Ferrer Internacional
11 3HIBROW HLTHCARE
12 1Mars Therapeutics
13 1Polfa Tarchomin
14 1Recordati
15 2Rising Pharmaceuticals Inc
16 1SIGMA TAU
17 1Saudi Pharmaceutical Industries
18 3Teva Pharmaceutical Industries
19 3Torrent Pharmaceuticals Limited
20 2UT Southwestern Medical Center
21 2Viatris
22 1West-Coast Pharmaceuticals
23 1XGX Pharma ApS
24 1Xgx Pharma Aps
25 3Zydus Pharmaceuticals
26 3Blank
01 1Capsule
02 2Extended Release Granule
03 1Extended Release Tablet
04 7Extended-Release Tablet
05 2FOR SOLUTION;ORAL
06 3Granules
07 2Modified Release Tablet
08 2Oral Solution
09 2Prolonged Release Granules
10 2SUS
11 1Syrup
12 1TABLET (EXTENDED-RELEASE)
13 27TABLET, EXTENDED RELEASE;ORAL
14 5Tablet
15 1Blank
01 1Allowed
02 3Authorized
03 1Cancelled
04 5DISCN
05 1Dossier Available
06 2Generic
07 2Marketed
08 2Not Marketed
09 4Prescription
10 24RX
11 14Blank
01 1Acalka
02 2Alkacite
03 1Aqualyte
04 1Biochetasi
05 2Gencit Simplex
06 1Kajos
07 26POTASSIUM CITRATE
08 1Potassion
09 6Potassium Citrate
10 6Sibnayal
11 1UROCIT
12 4UROCIT-K
13 1Uralyt-Urat, Granules For Oral Solution
14 6Blank
01 1Canada
02 1Denmark
03 2Estonia
04 11India
05 2Italy
06 4Norway
07 1Poland
08 1Saudi Arabia
09 2South Africa
10 4Spain
11 1Switzerland
12 29USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 1985-08-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 1992-08-31
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2009-12-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : UROCIT-K
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 1080MG
Packaging : 100
Approval Date :
Application Number : 2353997
Regulatory Info : Prescription
Registration Country : Canada
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 5MEq
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 10MEq
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 15MEq
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
